NFKB1 and Miyoshi myopathy: To provide a reliable characterization of NF-κB activity in myeloma cells at single-cell level, we exploited an integrated approach comprising MSCs and MM cells that express fluorescently tagged endogenous p65/NF-κB, high throughput live imaging, microfluidic devices, mathematical modelling, and bioinformatics.